Practice Bulletin No. 169: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies

Obstetrics and Gynecology

Volumn 128, Issue 4, 2016, Pages e131-e146

  Hayes, Edward J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; FIBRONECTIN; HYDROXYPROGESTERONE CAPROATE; MAGNESIUM SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE; UTERUS SPASMOLYTIC AGENT;

AMNIOCENTESIS; ANEUPLOIDY; BED REST; BIRTH; BRAIN HEMORRHAGE; CERCLAGE; CEREBRAL PALSY; CHORION; CHORION VILLUS SAMPLING; CORTICOSTEROID THERAPY; EVIDENCE BASED MEDICINE; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS MORTALITY; GESTATIONAL AGE; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT MORTALITY; INFERTILITY THERAPY; LABORATORY TEST; MATERNAL AGE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUROPROTECTION; NEWBORN MORBIDITY; OBSTETRIC DELIVERY; POSTPARTUM HEMORRHAGE; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; REPRODUCTION; REVIEW; THERAPEUTIC ABORTION; TOCOLYSIS; TWIN PREGNANCY; TWINS; UMBILICAL CORD COMPLICATION; UNITED STATES; UTERINE ATONY; VAGINA PESSARY; DIAGNOSTIC IMAGING; FEMALE; FETUS DEATH; FETUS DEVELOPMENT; PRACTICE GUIDELINE; PREGNANCY;

ADRENAL CORTEX HORMONES; CHORION; FEMALE; FETAL DEATH; FETAL DEVELOPMENT; GESTATIONAL AGE; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY REDUCTION, MULTIFETAL; PREGNANCY, MULTIPLE; PREMATURE BIRTH; TOCOLYTIC AGENTS; ULTRASONOGRAPHY, PRENATAL;

EID: 84988645737     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001709     Document Type: Review

References (139)

1. Martin JA, Hamilton BE, Osterman MJ. Three decades of twin births in the United States, 1980-2009. NCHS Data Brief 2012;80:1-8. (Level II-3) [PubMed]
2. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, et al. Births: final data for 2009. Natl Vital Rep 2011;60:1-70. (Level II-3) [PubMed]
3. Blondel B, Kaminski M. Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol 2002;26:239-49. (Level III) [PubMed]
4. Scher AI, Petterson B, Blair E, Ellenberg JH, Grether JK, Haan E, et al. The risk of mortality or cerebral palsy in twins a collaborative population-based study. Pediatr Res 2002;52:671-81. (Level II-3) [PubMed]
5. Rettwitz-Volk W, Tran TM, Veldman A. Cerebral morbidity in preterm twins. J Matern Fetal Neonatal Med 2003; 13:218-23. (Level II-3) [PubMed]
6. Yokoyama Y, Shimizu T, Hayakawa K. Prevalence of cerebral palsy in twins, triplets and quadruplets. Int J Epidemiol 1995;24:943-8. (Level II-3) [PubMed]
7. Bromer JG, Ata B, Seli M, Lockwood CJ, Seli E. Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA a cost analysis. Curr Opin Obstet Gynecol 2011;23: 168-73. (Cost-benefit) [PubMed]
8. Institute of Medicine. Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press; 2007. (Level III)
9. LeFevre ML, Bain RP, Ewigman BG, Frigoletto FD, Crane JP, McNellis D. A randomized trial of prenatal ultrasonographic screening: impact on maternal management and outcome. RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) Study Group. Am J Obstet Gynecol 1993;169:483-9. (Level I) [PubMed]
10. Geipel A, Berg C, Katalinic A, Plath H, Hansmann M, Germer U, et al. Prenatal diagnosis and obstetric outcomes in triplet pregnancies in relation to chorionicity. BJOG 2005;112:554-8. (Level II-3) [PubMed]
11. Glinianaia SV, Obeysekera MA, Sturgiss S, Bell R. Stillbirth and neonatal mortality in monochorionic and dichorionic twins a population-based study. Hum Reprod 2011;26:2549-57. (Level II-3) [PubMed]
12. Bajoria R, Ward SB, Adegbite AL. Comparative study of perinatal outcome of dichorionic and trichorionic iatrogenic triplets. Am J Obstet Gynecol 2006;194:415-24. (Level II-3) [PubMed]
13. Kawaguchi H, Ishii K, Yamamoto R, Hayashi S, Mitsuda N. Perinatal death of triplet pregnancies by chorionicity. Perinatal Research Network Group in Japan. Am J Obstet Gynecol 2013;209:36.e1-7. (Level II-3) [PubMed]
14. Sivan E, Maman E, Homko CJ, Lipitz S, Cohen S, Schiff E. Impact of fetal reduction on the incidence of gestational diabetes. Obstet Gynecol 2002;99:91-4. (Level II-3) [PubMed] [Obstetrics &Gynecology]
15. Schwartz DB, Daoud Y, Zazula P, Goyert G, Bronsteen R, Wright D, et al. Gestational diabetes mellitus: metabolic and blood glucose parameters in singleton versus twin pregnancies. Am J Obstet Gynecol 1999;181:912-4. (Level II-2) [PubMed]
16. Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:938-42. (Level II-3) [PubMed]
17. Luke B, Brown MB. Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality. Fertil Steril 2007;88:283-93. (Level II-3) [PubMed]
18. Conde-Agudelo A, Belizan JM, Lindmark G. Maternal morbidity and mortality associated with multiple gestations. Obstet Gynecol 2000;95:899-904. (Level II-3) [PubMed] [Obstetrics &Gynecology]
19. Sheard C, Cox S, Oates M, Ndukwe G, Glazebrook C. Impact of a multiple, IVF birth on post-partum mental health a composite analysis. Hum Reprod 2007;22: 2058-65. (Level III) [PubMed]
20. Bailit JL. Hyperemesis gravidarium: epidemiologic findings from a large cohort. Am J Obstet Gynecol 2005; 193:811-4. (Level II-3) [PubMed]
21. Day MC, Barton JR, O'Brien JM, Istwan NB, Sibai BM. The effect of fetal number on the development of hypertensive conditions of pregnancy. Obstet Gynecol 2005; 106:927-31. (Level II-3) [PubMed] [Obstetrics &Gynecology]
22. Lynch A, McDuffie R Jr, Murphy J, Faber K, Orleans M. Preeclampsia in multiple gestation: the role of assisted reproductive technologies. Obstet Gynecol 2002;99: 445-51.(Level II-3) [PubMed] [Obstetrics &Gynecology]
23. Hardardottir H, Kelly K, Bork MD, Cusick W, Campbell WA, Rodis JF. Atypical presentation of preeclampsia in high-order multifetal gestations. Obstet Gynecol 1996; 87:370-4. (Level III) [PubMed] [Obstetrics &Gynecology]
24. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981-91. (Level III) [PubMed] [Obstetrics &Gynecology]
25. Society for Assisted Reproductive Technology. Clinic summary report: all SART member clinics. Available at: https://www.sartcorsonline.com/rptCSR-PublicMultYear. aspx?ClinicPKID=0. Retrieved February 5, 2014. (Level III)
26. Dodd JM, Crowther CA. Reduction of the number of fetuses for women with a multiple pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 10 Art. No.: CD003932. DOI: 10.1002/14651858.CD003932. pub2. (Meta-analysis) [PubMed]
27. Smith-Levitin M, Kowalik A, Birnholz J, Skupski DW, Hutson JM, Chervenak FA, et al. Selective reduction of multifetal pregnancies to twins improves outcome over nonreduced triplet gestations. Am J Obstet Gynecol 1996;175:878-82. (Level III) [PubMed]
28. Berkowitz RL, Stone JL, Eddleman KA. One hundred consecutive cases of selective termination of an abnormal fetus in a multifetal gestation. Obstet Gynecol 1997; 90:606-10. (Level III) [PubMed] [Obstetrics &Gynecology]
29. Eddleman KA, Stone JL, Lynch L, Berkowitz RL. Selective termination of anomalous fetuses in multifetal pregnancies: two hundred cases at a single center. Am J Obstet Gynecol 2002;187:1168-72. (Level II-3) [PubMed]
30. Lust A, De Catte L, Lewi L, Deprest J, Loquet P, Devlieger R. Monochorionic and dichorionic twin pregnancies discordant for fetal anencephaly a systematic review of prenatal management options. Prenat Diagn 2008;28:275-9. (Level III) [PubMed]
31. Lynch L, Berkowitz RL, Stone J, Alvarez M, Lapinski R. Preterm delivery after selective termination in twin pregnancies. Obstet Gynecol 1996;87:366-9. (Level III) [PubMed] [Obstetrics &Gynecology]
32. Lee YM, Cleary-Goldman J, Thaker HM, Simpson LL. Antenatal sonographic prediction of twin chorionicity. Am J Obstet Gynecol 2006;195:863-7. (Level II-3) [PubMed]
33. Finberg HJ. The "twin peak" sign: reliable evidence of dichorionic twinning. J Ultrasound Med 1992;11:571-7. (Level III) [PubMed]
34. Reichmann JP. Home uterine activity monitoring: an evidence review of its utility in multiple gestations. J Reprod Med 2009;54:559-62. (Level III) [PubMed]
35. Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database of Systematic Reviews 2008, Issue 4 Art. No.: CD006843. DOI: 10.1002/14651858.CD006843. pub2. (Meta-analysis) [PubMed]
36. Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999; 180:581-6. (Level II-3) [PubMed]
37. Giles W, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol 2000;182:439-42. (Cost-benefit) [PubMed]
38. Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol 2004;191:235-40. (Level I) [PubMed]
39. Ness A, Visintine J, Ricci E, Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol 2007;197: 426.e1-7. (Level I) [PubMed]
40. Plaut MM, Smith W, Kennedy K. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms. Am J Obstet Gynecol 2003;188:1588-93; discussion 1593-5. (Level I) [PubMed]
41. Dor J, Shalev J, Mashiach S, Blankstein J, Serr DM. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following induced ovulation. Gynecol Obstet Invest 1982;13:55-60. (Level I) [PubMed]
42. Rebarber A, Roman AS, Istwan N, Rhea D, Stanziano G. Prophylactic cerclage in the management of triplet pregnancies. Am J Obstet Gynecol 2005;193:1193-6. (Level II-3) [PubMed]
43. Moragianni VA, Aronis KN, Craparo FJ. Biweekly ultrasound assessment of cervical shortening in triplet pregnancies and the effect of cerclage placement. Ultrasound Obstet Gynecol 2011;37:617-8. (Level III) [PubMed]
44. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005;106:181-9. (Meta-analysis) [PubMed] [Obstetrics &Gynecology]
45. Roman AS, Saltzman DH, Fox N, Klauser CK, Istwan N, Rhea D, et al. Prophylactic cerclage in the management of twin pregnancies. Am J Perinatol 2013;30:751-4. (Level II-3) [PubMed]
46. Crowther CA, Han S. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 7 Art. No.: CD000110. DOI: 10.1002/ 14651858.CD000110.pub2. (Meta-analysis) [PubMed]
47. Wilkins IA, Lynch L, Mehalek KE, Berkowitz GS, Berkowitz RL. Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol 1988;159:685-9. (Level I) [PubMed]
48. Samol JM, Lambers DS. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle? Am J Obstet Gynecol 2005;192:1430-2. (Level II-3) [PubMed]
49. Cetrulo CL, Freeman RK. Ritodrine HCL for the prevention of premature labor in twin pregnancies. Acta Genet Med Gemellol 1976;25:321-4. (Level III) [PubMed]
50. O'Leary JA. Prophylactic tocolysis of twins. Am J Obstet Gynecol 1986;154:904-5. (Level III) [PubMed]
51. Ashworth MF, Spooner SF, Verkuyl DA, Waterman R, Ashurst HM. Failure to prevent preterm labour and delivery in twin pregnancy using prophylactic oral salbutamol. Br J Obstet Gynaecol 1990;97:878-82. (Level I). [PubMed]
52. Yamasmit W, Chaithongwongwatthana S, Tolosa JE, Limpongsanurak S, Pereira L, Lumbiganon P. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 9 Art. No.: CD004733. DOI: 10.1002/ 14651858.CD004733.pub3. (Meta-analysis) [PubMed]
53. Fletcher SE, Fyfe DA, Case CL, Wiles HB, Upshur JK, Newman RB. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor. Am J Obstet Gynecol 1991;165:1401-4. (Level III) [PubMed]
54. Gabriel R, Harika G, Saniez D, Durot S, Quereux C, Wahl P. Prolonged intravenous ritodrine therapy a comparison between multiple and singleton pregnancies. Eur J Obstet Gynecol Reprod Biol 1994;57:65-71. (Level II-3) [PubMed]
55. Food and Drug Administration. FDA drug safety communication: new warnings against use of terbutaline to treat preterm labor. Silver Spring (MD): FDA; 2011. Available at: http://www.fda.gov/drugs/drugsafety/ucm 243539.htm. Retrieved January 31, 2014. (Level III)
56. Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN) a multicentre, open-label randomised controlled trial. Lancet 2013;382:1341-9. (Level I) [PubMed]
57. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. N Engl J Med 2007;357:454-61. (Level I) [PubMed]
58. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT) a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009;373:2034-40. (Level I) [PubMed]
59. Combs CA, Garite T, Maurel K, Das A, Porto M. 17-hydroxyprogesterone caproate for twin pregnancy a double-blind, randomized clinical trial. Obstetrix Collaborative Research Network. Am J Obstet Gynecol 2011;204:221.e1-221.e8. (Level I) [PubMed]
60. Combs CA, Garite T, Maurel K, Das A, Porto M. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy a double-blind, randomized clinical trial. Obstetrix Collaborative Research Network [published erratum appears in Am J Obstet Gynecol 2011;204:166]. Am J Obstet Gynecol 2010;203:248. e1-9. (Level I) [PubMed]
61. Caritis SN, Rouse DJ, Peaceman AM, Sciscione A, Momirova V, Spong CY, et al. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate a randomized controlled trial. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU). Obstet Gynecol 2009;113:285-92. (Level I) [PubMed] [Obstetrics &Gynecology]
62. Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, et al. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-alpha hydroxyprogesterone caproate. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. J Matern Fetal Neonatal Med 2010;23:1360-4. (Level II-3) [PubMed]
63. Wood S, Ross S, Tang S, Miller L, Sauve R, Brant R. Vaginal progesterone to prevent preterm birth in multiple pregnancy a randomized controlled trial. J Perinat Med 2012;DOI: 10.1515/jpm-2012-0057. (Level I) [PubMed]
64. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. Fetal Medicine Foundation Second Trimester Screening Group. N Engl J Med 2007; 357:462-9. (Level I) [PubMed]
65. Romero J, Rebarber A, Saltzman DH, Schwartz R, Peress D, Fox NS. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length. Am J Obstet Gynecol 2012;207:51.e1-5. (Level II-3) [PubMed]
66. Senat MV, Porcher R, Winer N, Vayssiere C, Deruelle P, Capelle M, et al. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix a randomized controlled trial. Groupe de Recherche en Obstetrique et Gynecologie. Am J Obstet Gynecol 2013;208:194.e1-8. (Level I) [PubMed]
67. Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, et al. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies a randomised controlled double-blind multicentre trial. BJOG 2013;120:50-7. (Level I) [PubMed]
68. Haas DM, Quinney SK, Clay JM, Renbarger JL, Hebert MF, Clark S, et al. Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Obstetric-Fetal Pharmacology Research Units Network. Am J Perinatol 2013;30:275-81. (Level III) [PubMed]
69. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3 Art. No.: CD004454. DOI: 10.1002/1465 1858.CD004454.pub2. (Meta-analysis) [PubMed]
70. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 1994;12(2):1-24. (Level III) [PubMed]
71. Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 677. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e187-94
72. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth a randomized controlled trial. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. JAMA 2003;290:2669-76. (Level I) [PubMed]
73. Marret S, Marpeau L, Zupan-Simunek V, Eurin D, Leveque C, Hellot MF, et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial. PREMAG trial group. BJOG 2007;114:310-8. (Level I) [PubMed]
74. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. N Engl J Med 2008;359:895-905. (Level I) [PubMed]
75. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1 Art. No.: CD004661. DOI: 10.1002/14651858.CD004661.pub3. (Meta-analysis) [PubMed]
76. Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation a systematic review and metaanalysis. Am J Obstet Gynecol 2009;200:595-609. (Meta-analysis) [PubMed]
77. Costantine MM, Weiner SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants a meta-analysis. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2009;114:354-64. (Meta-analysis) [PubMed] [Obstetrics &Gynecology]
78. Magnesium sulfate before anticipated preterm birth for neuroprotection. Committee Opinion No. 455. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;115:669-71. (Level III) [PubMed] [Obstetrics &Gynecology]
79. Meyers C, Adam R, Dungan J, Prenger V. Aneuploidy in twin gestations: when is maternal age advanced? Obstet Gynecol 1997;89:248-51. (Level III) [PubMed] [Obstetrics &Gynecology]
80. Rodis JF, Egan JF, Craffey A, Ciarleglio L, Greenstein RM, Scorza WE. Calculated risk of chromosomal abnormalities in twin gestations. Obstet Gynecol 1990;76:1037-41. (Level III) [PubMed] [Obstetrics &Gynecology]
81. Garchet-Beaudron A, Dreux S, Leporrier N, Oury JF, Muller F. Second-trimester Down syndrome maternal serum marker screening a prospective study of 11 040 twin pregnancies. ABA Study Group, Clinical Study Group. Prenat Diagn 2008;28:1105-9. (Level III) [PubMed]
82. Bush MC, Malone FD. Down syndrome screening in twins. Clin Perinatol 2005;32:373-86, vi. (Level III) [PubMed]
83. Chasen ST, Perni SC, Kalish RB, Chervenak FA. Firsttrimester risk assessment for trisomies 21 and 18 in twin pregnancy. Am J Obstet Gynecol 2007;197:374.e1-3. (Level II-3) [PubMed]
84. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1996;103:999-1003. (Level II-3) [PubMed]
85. Sepulveda W, Wong AE, Casasbuenas A. Nuchal translucency and nasal bone in first-trimester ultrasound screening for aneuploidy in multiple pregnancies. Ultrasound Obstet Gynecol 2009;33:152-6. (Level III) [PubMed]
86. Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twinto-twin transfusion syndrome. Ultrasound Obstet Gynecol 1997;10:86-9. (Level II-3) [PubMed]
87. Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012; 120:1532-4. (Level III) [PubMed] [Obstetrics &Gynecology]
88. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies a systematic review. Ultrasound Obstet Gynecol 2012;40:128-34. (Meta-analysis) [PubMed]
89. Simonazzi G, Curti A, Farina A, Pilu G, Bovicelli L, Rizzo N. Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique? Am J Obstet Gynecol 2010;202:365.e1-5. (Level II-3) [PubMed]
90. Cahill AG, Macones GA, Stamilio DM, Dicke JM, Crane JP, Odibo AO. Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol 2009;200:257.e1-6. (Level II-3) [PubMed]
91. Eddleman KA, Stone JL, Lynch L, Berkowitz RL. Chorionic villus sampling before multifetal pregnancy reduction. Am J Obstet Gynecol 2000;183:1078-81. (Level III) [PubMed]
92. Talbot GT, Goldstein RF, Nesbitt T, Johnson JL, Kay HH. Is size discordancy an indication for delivery of preterm twins? Am J Obstet Gynecol 1997;177:1050-4. (Level III) [PubMed]
93. Breathnach FM, McAuliffe FM, Geary M, Daly S, Higgins JR, Dornan J, et al. Perinatal Ireland Research Consortiu. Definition of intertwin birth weight discordance. Obstet Gynecol. 2011 Jul;118(1):94-103. DOI: 10.1097/AOG.0b013e31821fd208. [PubMed] [Obstetrics &Gynecology]
94. Lopriore E, Slaghekke F, Vandenbussche FP, Middeldorp JM, Walther FJ, Oepkes D. Cerebral injury in monochorionic twins with selective intrauterine growth restriction and/or birthweight discordance. Am J Obstet Gynecol 2008;199:628.e1-5. (Level II-3) [PubMed]
95. Appleton C, Pinto L, Centeno M, Clode N, Cardoso C, Graca LM. Near term twin pregnancy: clinical relevance of weight discordance at birth. J Perinat Med 2007;35: 62-6. (Level II-3) [PubMed]
96. Cohen SB, Elizur SE, Goldenberg M, Beiner M, Novikov I, Mashiach S, et al. Outcome of twin pregnancies with extreme weight discordancy. Am J Perinatol 2001;18: 427-32. (Level II-3) [PubMed]
97. Kilic M, Aygun C, Kaynar-Tuncel E, Kucukoduk S. Does birth weight discordance in preterm twins affect neonatal outcome? J Perinatol 2006;26:268-72. (Level II-3) [PubMed]
98. Yinon Y, Mazkereth R, Rosentzweig N, Jarus-Hakak A, Schiff E, Simchen MJ. Growth restriction as a determinant of outcome in preterm discordant twins. Obstet Gynecol 2005;105:80-4. (Level II-3) [PubMed] [Obstetrics &Gynecology]
99. Odibo AO, McDonald RE, Stamilio DM, Ural SH, Macones GA. Perinatal outcomes in growth-restricted twins compared with age-matched growth-restricted singletons. Am J Perinatol 2005;22:269-73. (Level II-3) [PubMed]
100. Landy HJ, Keith LG. The vanishing twin a review. Hum Reprod Update 1998;4:177-83. (Level III) [PubMed]
101. Dickey RP, Taylor SN, Lu PY, Sartor BM, Storment JM, Rye PH, et al. Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. Am J Obstet Gynecol 2002;186:77-83. (Level II-3) [PubMed]
102. D'Alton ME, Simpson LL. Syndromes in twins. Semin Perinatol 1995;19:375-86. (Level III) [PubMed]
103. Lee YM, Wylie BJ, Simpson LL, D'Alton ME. Twin chorionicity and the risk of stillbirth [published erratum appears in Obstet Gynecol 2008;111:1217]. Obstet Gynecol 2008;111:301-8. (Level II-3) [PubMed] [Obstetrics &Gynecology]
104. Morikawa M, Yamada T, Yamada T, Sato S, Cho K, Minakami H. Prospective risk of stillbirth: monochorionic diamniotic twins vs. dichorionic twins. J Perinat Med 2012;40:245-9. (Level II-3) [PubMed]
105. Danon D, Sekar R, Hack KE, Fisk NM. Increased stillbirth in uncomplicated monochorionic twin pregnancies a systematic review and meta-analysis. Obstet Gynecol 2013;121:1318-26. (Meta-analysis) [PubMed] [Obstetrics &Gynecology]
106. Hillman SC, Morris RK, Kilby MD. Co-twin prognosis after single fetal death a systematic review and metaanalysis. Obstet Gynecol 2011;118:928-40. (Metaanalysis) [PubMed] [Obstetrics &Gynecology]
107. Ong SS, Zamora J, Khan KS, Kilby MD. Prognosis for the co-twin following single-twin death a systematic review. BJOG 2006;113:992-8. (Meta-analysis) [PubMed]
108. Karageyim Karsidag AY, Kars B, Dansuk R, Api O, Unal O, Turan MC, et al. Brain damage to the survivor within 30 min of co-twin demise in monochorionic twins. Fetal Diagn Ther 2005;20:91-5. (Level III) [PubMed]
109. Spong CY, Mercer BM, D'Alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011;118:323-33. (Level III) [PubMed] [Obstetrics &Gynecology]
110. Alexander GR, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States? Clin Obstet Gynecol 1998;41: 114-25. (Level II-3) [PubMed]
111. Giles W, Bisits A, O'Callaghan S, Gill A. The Doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy. DAMP Study Group. BJOG 2003;110:593-7. (Level I) [PubMed]
112. Twin-twin transfusion syndrome. Society for Maternal-Fetal Medicine [published erratum appears in Am J Obstet Gynecol 2013;208:392]. Am J Obstet Gynecol 2013;208:3-18. (Level III) [PubMed]
113. Sueters M, Middeldorp JM, Lopriore E, Oepkes D, Kanhai HH, Vandenbussche FP. Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms. Ultrasound Obstet Gynecol 2006;28:659-64. (Level III) [PubMed]
114. Royal College of Obstetricians and Gynaecologists. Consensus views arising from the 50th Study Group: multiple pregnancy. London: RCOG; 2006. Available at: http://www.rcog.org.uk/files/rcog-corp/uploaded-files/ StudyGroupConsensusViewsMultiplePregnancy.pdf. Retrieved February 5, 2014. (Level III)
115. Lewi L, Gucciardo L, Van Mieghem T, de Koninck P, Beck V, Medek H, et al. Monochorionic diamniotic twin pregnancies: natural history and risk stratification. Fetal Diagn Ther 2010;27:121-33. (Level III). [PubMed]
116. Stamilio DM, Fraser WD, Moore TR. Twin-twin transfusion syndrome: an ethics-based and evidence-based argument for clinical research. Am J Obstet Gynecol 2010;203:3-16. (Level III) [PubMed]
117. Slotnick RN, Ortega JE. Monoamniotic twinning and zona manipulation a survey of U.S. IVF centers correlating zona manipulation procedures and high-risk twinning frequency. J Assist Reprod Genet 1996;13:381-5. (Level III) [PubMed]
118. Baxi LV, Walsh CA. Monoamniotic twins in contemporary practice a single-center study of perinatal outcomes. J Matern Fetal Neonatal Med 2010;23:506-10. (Level III) [PubMed]
119. DeFalco LM, Sciscione AC, Megerian G, Tolosa J, Macones G, O'Shea A, et al. Inpatient versus outpatient management of monoamniotic twins and outcomes. Am J Perinatol 2006;23:205-11. (Level III) [PubMed]
120. Ezra Y, Shveiky D, Ophir E, Nadjari M, Eisenberg VH, Samueloff A, et al. Intensive management and early delivery reduce antenatal mortality in monoamniotic twin pregnancies. Acta Obstet Gynecol Scand 2005;84:432-5. (Level III) [PubMed]
121. Sogaard K, Skibsted L, Brocks V. Acardiac twins: pathophysiology, diagnosis, outcome and treatment. Six cases and review of the literature. Fetal Diagn Ther 1999;14:53-9. (Level III) [PubMed]
122. van Gemert MJ, Umur A, Wijngaard JP, Bavel E, Vandenbussche FP, Nikkels PG. Increasing cardiac output and decreasing oxygenation sequence in pump twins of acardiac twin pregnancies. Phys Med Biol 2005;50:N33-42. (Level III) [PubMed]
123. Mutchinick OM, Luna-Munoz L, Amar E, Bakker MK, Clementi M, Cocchi G, et al. Conjoined twins a worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet 2011;157:274-87. (Level II-3) [PubMed]
124. Spitz L, Kiely EM. Conjoined twins. JAMA 2003;289: 1307-10. (Level III) [PubMed]
125. Mackenzie TC, Crombleholme TM, Johnson MP, Schnaufer L, Flake AW, Hedrick HL, et al. The natural history of prenatally diagnosed conjoined twins. J Pediatr Surg 2002;37:303-9. (Level III) [PubMed]
126. Refuerzo JS, Momirova V, Peaceman AM, Sciscione A, Rouse DJ, Caritis SN, et al. Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term. Am J Perinatol 2010;27:537-42. (Level II-3) [PubMed]
127. Cheung YB, Yip P, Karlberg J. Mortality of twins and singletons by gestational age a varying-coefficient approach. Am J Epidemiol 2000;152:1107-16. (Level II-3) [PubMed]
128. Crowther CA. Caesarean delivery for the second twin. Cochrane Database of Systematic Reviews 2011, Issue 12 Art. No.: CD000047. DOI: 10.1002/14651858. CD000047.pub2. (Level III)
129. Barrett JF, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, et al. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. Twin Birth Study Collaborative Group [published erratum appears in N Engl J Med 2013;369:2364]. N Engl J Med 2013;369:1295-305. (Level I) [PubMed]
130. D'Alton ME. Delivery of the second twin: revisiting the age-old dilemma. Obstet Gynecol 2010;115:221-2. (Level III) [PubMed] [Obstetrics &Gynecology]
131. Grobman WA, Peaceman AM, Haney EI, Silver RK, MacGregor SN. Neonatal outcomes in triplet gestations after a trial of labor. Am J Obstet Gynecol 1998;179: 942-5. (Level II-2) [PubMed]
132. Alamia V Jr, Royek AB, Jaekle RK, Meyer BA. Preliminary experience with a prospective protocol for planned vaginal delivery of triplet gestations. Am J Obstet Gynecol 1998;179:1133-5. (Level III) [PubMed]
133. Wildschut HI, van Roosmalen J, van Leeuwen E, Keirse MJ. Planned abdominal compared with planned vaginal birth in triplet pregnancies. Br J Obstet Gynaecol 1995;102:292-6. (Level III) [PubMed]
134. Sansregret A, Bujold E, Gauthier RJ. Twin delivery after a previous caesarean a twelve-year experience. J Obstet Gynaecol Can 2003;25:294-8. (Level III) [PubMed]
135. Cahill A, Stamilio DM, Pare E, Peipert JP, Stevens EJ, Nelson DB, et al. Vaginal birth after cesarean (VBAC) attempt in twin pregnancies: is it safe? Am J Obstet Gynecol 2005;193:1050-5. (Level II-3) [PubMed]
136. Varner MW, Thom E, Spong CY, Landon MB, Leveno KJ, Rouse DJ, et al. Trial of labor after one previous cesarean delivery for multifetal gestation. National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Obstet Gynecol 2007;110:814-9. (Level II-3) [PubMed] [Obstetrics &Gynecology]
137. Myles T. Vaginal birth of twins after a previous Cesarean section. J Matern Fetal Med 2001;10:171-4. (Level II-2) [PubMed]
138. Miller DA, Mullin P, Hou D, Paul RH. Vaginal birth after cesarean section in twin gestation. Am J Obstet Gynecol 1996;175:194-8. (Level II-3) [PubMed]
139. Francois K, Ortiz J, Harris C, Foley MR, Elliott JP. Is peripartum hysterectomy more common in multiple gestations? Obstet Gynecol 2005;105:1369-72. (Level II-3) [PubMed] [Obstetrics &Gynecology]